Thomas F. Gajewski to gp100 Melanoma Antigen
This is a "connection" page, showing publications Thomas F. Gajewski has written about gp100 Melanoma Antigen.
Connection Strength
0.085
-
Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites. Cancer Immunol Immunother. 2006 Oct; 55(10):1185-97.
Score: 0.068
-
Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901. J Immunother. 2006 Jan-Feb; 29(1):95-101.
Score: 0.017